Literature DB >> 8125078

The role of peptides and their receptors as tumor markers.

J C Reubi1.   

Abstract

This article focuses on the role of peptides and peptide receptors as in vitro and in vivo markers for several human malignancies. Neuroendocrine or similar neoplasms can produce excessive quantities of peptides, which may be used as diagnostic markers. Recent studies demonstrate that several tumor types express excessive amounts of peptide receptors, which also may be considered as potentially valuable tumor markers. The considerable progress made in the field of peptide receptors in oncology, ranging from test-tube work in the laboratory to challenging diagnostic possibilities in the clinic, is reviewed in detail with particular emphasis on the peptide somatostatin and its receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8125078

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphy.

Authors:  G Iser; M Pfohl; U Dörr; E M Weiss; F J Seif
Journal:  Clin Investig       Date:  1994-11

2.  Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.

Authors:  Martin Béhé; Wolfgang Becker; Martin Gotthardt; Christa Angerstein; Thomas M Behr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-24       Impact factor: 9.236

Review 3.  The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.

Authors:  Monique R Bernsen; Pieter E B Vaissier; Roel Van Holen; Jan Booij; Freek J Beekman; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.